GGrantIndex
← Search

Buffett Cancer Center Supplement to Strengthen Research, Training, and Outreach

$200,000P30FY2024CANIH

University Of Nebraska Medical Center, Omaha NE

Investigators

Linked publications, trials & patents

Paper 39684445Paper 39678719Paper 39605468Paper 39580490Paper 39573886Paper 39456534Paper 39450301Paper 39436320Paper 39420209Paper 39386613Paper 39386448Paper 39384153Paper 39339419Paper 39224072Paper 39219576Paper 39151112Paper 39141488Paper 39130636Paper 39125017Paper 39110778Paper 39107463Paper 39080401Paper 39013847Paper 38974465Paper 38969056Paper 38946943Paper 38900505Paper 38853862Paper 38847506Paper 38775157Paper 38770637Paper 38733583Paper 38712184Paper 38704607Paper 38687198Paper 38683788Paper 38672426Paper 38617282Paper 38603627Paper 38547055Paper 38542184Paper 38514303Paper 38482976Paper 38445903Paper 38437585Paper 38429478Trial NCT03226418Trial NCT03073785Trial NCT02874404Trial NCT02833701Trial NCT02654119Trial NCT02561273Trial NCT02553447Trial NCT02168270Trial NCT01959672Trial NCT01825603Trial NCT01750073Trial NCT01555632Trial NCT01431209Trial NCT01336933Trial NCT01336920Trial NCT01307956Trial NCT01106898Trial NCT01093183Trial NCT01068327Trial NCT01044745Trial NCT01035463Trial NCT00959244Trial NCT00856037Trial NCT00816413Trial NCT00736450Trial NCT00679029Trial NCT00666731Trial NCT00665457Trial NCT00625690Trial NCT00617799Trial NCT00611351Trial NCT00607828Trial NCT00602797Trial NCT00577798Trial NCT00569543Trial NCT00503880Trial NCT00499083Trial NCT00496756Trial NCT00486356Trial NCT00483561Trial NCT00483366Trial NCT00482807Trial NCT00089024Trial NCT00082641Trial NCT00007865Trial NCT00007852Trial NCT00006478Trial NCT00004874Trial NCT00004198Trial NCT00004197Trial NCT00004192Trial NCT00004112Patent 7166704Patent 6680196

Abstract

Project Summary The Fred & Pamela Buffett Cancer Center (also known as the Buffett Cancer Center) is the only National Cancer Institute (NCI)-designated cancer center in Nebraska. The Buffett Cancer Center is a matrix cancer center at the University of Nebraska Medical Center and its affiliated healthcare network, Nebraska Medicine. The mission of the Buffett Cancer Center is to promote innovative translational cancer research, excellence in cancer education and training, and outstanding patient-centered cancer care to reduce the burden of cancer and cancer health disparities across Nebraska and beyond. Due to its specific demographics, Nebraska needs capabilities in cancer research training and cancer disparities research targeted to the American Indian, Hispanic, rural, and financially disadvantaged populations, which in Nebraska are groups that substantially overlap. The Buffett Cancer Center (and the University of Nebraska as a whole) encourages the entry of members of these groups into health careers by pathway programs for middle school, high school, and college students. However, there is a growing necessity for strategies to bridge the continuation of these underrepresented minority students further into graduate/professional programs and faculty positions. Therefore, consistent with the mission of the Buffett Cancer Center and the goals of the NCI, this administrative supplement extension will specifically address the need for cancer research training at the level of predoctoral, postdoctoral, and early investigator scholars, with a focus on scholars with American Indian, Hispanic, rural, and/or financially disadvantaged backgrounds. Our objective is to use focused strategies to enhance the development of these scholars, thereby facilitating their readiness for successful careers in cancer research and care and their ability to alleviate cancer disparities, and to assess the results of our approach. Our Specific Aims for this supplement extension are as follows: (1) to sustain the guidance of diverse scholars into cancer research pathways, (2) to maintain advancement of diverse scholars through NCI workforce opportunities, and (3) to evaluate and disseminate the outcomes of this Training Navigator Program. The Buffett Cancer Center is fully committed to attain progress in these Aims during the supplement period and to sustain these efforts beyond the supplement extension’s conclusion.

View original record on NIH RePORTER →